Metsa Board Oyj Class B METSB

Mäki will remain at the helm through the end of May before moving into an advisory capacity for the remainder of 2027.

On 2 January 2026, Schouw & Co. initiated a share buy-back programme as outlined in Company Announcement no. 59 of 18 December 2025. Under the programme, Schouw & Co. will acquire shares for up to DKK 240 million during the period 2 January to 31 December 2026. As outlined in Company Announcement no. 48 of 14 August 2026, the programme was extended with up to DKK 170 million, increasing the total amount of which Schouw & Co. will acquire shares to up to DKK 410 million. The buy-back will be stru

The traditional retirement planning approaches no longer cover all expenses in nest egg years. So what can retirees do? Thankfully, there are alternative investments that provide steady, higher-rate income streams to replace dwindling bond yields.

Oligo Medic Inc., today announced that it has entered into a letter of intent to acquire the imaging-based custom implant business of Episurf Medical AB, which develops and commercializes patient-specific implants and surgical instruments for joint preservation.

Mochida Pharmaceutical Co., Ltd. (Head Office: Shinjuku-ku, Tokyo, Japan; President: Naoyuki Mochida; hereinafter "Mochida") and Duchesnay Inc. (Head Office: Quebec, Canada; President: Éric Gervais; hereinafter "Duchesnay") announce the initiation of a Phase III clinical study (the "Study") of BON-001 (the "Product") for nausea and vomiting of pregnancy in Japan.

WILMINGTON, DELAWARE, Oct. 26, 2026 (GLOBE NEWSWIRE) -- CID HoldCo, Inc., doing business as Dot Ai (Nasdaq: DAIC) (“Dot Ai” or the “Company”), today announced the appointment of Avi Cohen to its Board of Directors. Cohen brings extensive experience leading technology companies through acquisitions, integration and expansion as Dot Ai enters its next phase of growth following the recent $65 million acquisition of its wholly owned subsidiary, Envoy Technologies. As CEO of RR Media, Cohen oversaw a

Saskatoon, Saskatchewan--(Newsfile Corp. - October 26, 2026) - MustGrow Biologics Corp. (TSXV: MGRO) (OTCQB: MGROF) (FSE: 0C0) (the "Company" or "MustGrow") announces an upcoming webcast panel discussion with Bayer AG (BAYN) ("Bayer") featuring MustGrow's Chief Operating Officer Colin Bletsky with Ralf Glaubitz, Head of Crop Protection Product Team Biologicals at Bayer's Crop Science division. The "fireside chat" panel discussion will be broadcasted on:Wednesday, October 28, 2026 at 4:05pm...

As the fall 2026 literary season unfolds, daily pronouncements on AI are coming at a relentless pace from the publishing world and literary prize organizations: rejection of AI-generated writing, tolerance of AI assistance with research, disclosure requirements, or recognition of creative work produced with AI.

HONG KONG, Oct. 26, 2026 (GLOBE NEWSWIRE) -- Recently, Berlin Global Dialogue (BGD) 2026 and the Invest in Germany Summit were held concurrently in Berlin, Germany. Xunce (3317.HK) was invited to attend as a strategic partner. The company’s management and representatives participated in relevant events and held in-depth exchanges with stakeholders from all sectors on topics including AI data infrastructure and China-Europe data cooperation. Seizing this opportunity, the company’s new-generation

Investing.com -- Dutch postal group PostNL said on Monday it had applied for state compensation for 2027 after political delays to postal law reform made a planned shift to slower mail delivery unworkable, while confirming its 2026 outlook.

AT & S Austria Technologie & Systemtechnik is back in focus after analysts lifted their price targets into a range around €220 to €320, which feeds into a higher fair value estimate. These refreshed targets sit on a mix of more positive ratings and ongoing questions about execution, valuation and how the current project pipeline plays out. Read on to see what is driving the updated narrative and how you can track the next moves in AT & S Austria Technologie & Systemtechnik. Analyst Price...

The Federal Reserve’s signal that interest rates are likely on hold for now has put growth stories back on many watchlists. Cheaper borrowing costs can matter a lot when a business needs capital to expand. That is where fast growing companies with executives owning a meaningful slice of the shares can be interesting. This piece highlights three such stocks and explains why insiders’ skin in the game may appeal to long term investors. The three stocks highlighted here offer a compelling...